Edition:
United Kingdom

Anthem Inc (ANTM.N)

ANTM.N on New York Stock Exchange

248.52USD
20 Jul 2018
Change (% chg)

$-0.12 (-0.05%)
Prev Close
$248.64
Open
$246.59
Day's High
$249.14
Day's Low
$246.37
Volume
269,862
Avg. Vol
383,931
52-wk High
$264.85
52-wk Low
$179.44

Latest Key Developments (Source: Significant Developments)

Jana Partners LLC Takes Sole Share Stake In Allergan, Boston Scientific
Tuesday, 15 May 2018 

May 15 (Reuters) - Jana Partners LLC ::JANA PARTNERS LLC TAKES SOLE SHARE STAKE IN ALLERGAN PLC OF 12,000 SHARES - SEC FILING.JANA PARTNERS LLC TAKES SOLE SHARE STAKE IN AGILENT TECHNOLOGIES INC OF 1.0 MILLION SHARES.JANA PARTNERS LLC TAKES SOLE SHARE STAKE IN ANTHEM INC OF 610,593 SHARES.JANA PARTNERS LLC DISSOLVES SOLE SHARE STAKE IN W W GRAINGER INC.JANA PARTNERS LLC TAKES SOLE SHARE STAKE IN BOSTON SCIENTIFIC CORP OF 4.7 MILLION SHARES.JANA PARTNERS LLC - CHANGE IN HOLDINGS ARE AS OF MARCH 31, 2018 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF DEC 31, 2017.  Full Article

Diplomat Pharmacy Appoints Brian Griffin As CEO And Chairman Of Board
Thursday, 10 May 2018 

May 10 (Reuters) - Diplomat Pharmacy Inc ::DIPLOMAT PHARMACY APPOINTS BRIAN GRIFFIN AS CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD.DIPLOMAT PHARMACY INC - BOARD WILL EXPAND TO EIGHT MEMBERS WITH GRIFFIN'S APPOINTMENT.  Full Article

Anthem Chief Operating Officer Deepti Jain To Lead Ingeniorx
Thursday, 10 May 2018 

May 10 (Reuters) - Anthem Inc ::CHIEF OPERATING OFFICER DEEPTI JAIN TO LEAD INGENIORX.ANTHEM INC - DEEPTI JAIN WILL LEAD INGENIORX, ANTHEM'S NEWLY LAUNCHED PHARMACY BENEFITS MANAGER.ANTHEM INC - CONDUCTING EXTERNAL SEARCH TO FILL INGENIORX CEO ROLE FOLLOWING DEPARTURE OF BRIAN GRIFFIN, WHO HAS RESIGNED FROM COMPANY.  Full Article

Anthem Q4 Earnings Per Share $4.67
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Anthem Inc ::ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS REFLECTING BALANCED PERFORMANCE ACROSS ITS BUSINESS UNITS.Q4 EARNINGS PER SHARE $4.67.Q4 REVENUE ROSE 5.8 PERCENT TO $89.1 BILLION.Q4 REVENUE VIEW $22.21 BILLION -- THOMSON REUTERS I/B/E/S.Q4 EARNINGS PER SHARE VIEW $1.27 -- THOMSON REUTERS I/B/E/S.Q4 ADJUSTED EARNINGS PER SHARE $1.29.BENEFIT EXPENSE RATIO WAS 88.6 PERCENT IN Q4 OF 2017, AN INCREASE OF 140 BASIS POINTS FROM 87.2 PERCENT IN PRIOR YEAR QUARTER.BOARD OF DIRECTORS INCREASES QUARTERLY DIVIDEND BY 7.1% TO $0.75 PER SHARE.‍EXPECTS ITS FULL YEAR 2018 NET INCOME TO BE GREATER THAN $14.28 PER SHARE​.‍ FULL YEAR 2018 ADJUSTED NET INCOME IS EXPECTED TO BE GREATER THAN $15.00 PER SHARE​.MEDICAL ENROLLMENT TOTALED ABOUT 40.2 MILLION MEMBERS AT DECEMBER 31, 2017, INCREASE OF 325,000 MEMBERS.ANTICIPATES LOCAL GROUP MEDICAL COST TREND WILL BE IN RANGE OF 6.0% +/- 50 BASIS POINTS IN 2018.ANTHEM - Q4 NET INCOME INCLUDED NET POSITIVE ADJUSTMENT ITEMS OF $3.38/SHARE OF WHICH $4.21 RELATES TO A ONE-TIME, NON-CASH DEFERRED TAX BENEFIT.ANTHEM - ‍ 2018 OUTLOOK INCLUDES NET BENEFIT FROM TAX REFORM OF ABOUT $2.00 PER SHARE AFTER ADJUSTING FOR EXPECTED PREMIUM REDUCTIONS, AMONG OTHERS​.‍ FULL YEAR 2018 MEDICAL MEMBERSHIP IS EXPECTED TO BE IN RANGE OF 40,000,000 - 40,200,000​.2018 OPERATING REVENUE IS EXPECTED TO BE IN RANGE OF $90.5 - $91.5 BILLION.2018 OPERATING CASH FLOW IS EXPECTED TO BE GREATER THAN $4.0 BILLION.  Full Article

Anthem Inc - Board Increased Company's Share Repurchase Authorization By $5 Billion
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Anthem Inc ::ANTHEM INC - ON DECEMBER 7, 2017, BOARD INCREASED COMPANY'S SHARE REPURCHASE AUTHORIZATION BY $5 BILLION.ANTHEM INC - ALONG WITH NEW BUYBACK PROGRAM, CURRENT TOTAL AMOUNT AVAILABLE FOR SHARE REPURCHASES IS ABOUT $7.3 BILLION.  Full Article

Antonio Neri Joins Anthem’s Board As New Director
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Anthem Inc ::ANTHEM’S BOARD WELCOMES ANTONIO NERI AS NEW DIRECTOR.ANTHEM INC - ANTONIO NERI HAS BEEN NAMED TO ITS BOARD OF DIRECTORS EFFECTIVE DECEMBER 6, 2017.  Full Article

Anthem Files For Potential Mixed Shelf Offering; Size Not Disclosed
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Anthem Inc ::ANTHEM INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING‍​.  Full Article

Anthem Announces Pricing Of Its Tender Offer For Notes Due 2034, 2036, 2037, 2040 And 2044
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Anthem Inc ::ANTHEM ANNOUNCES PRICING OF ITS TENDER OFFER FOR NOTES DUE 2034, 2036, 2037, 2040 AND 2044.ANTHEM INC - PRICING OF ITS PREVIOUSLY ANNOUNCED CASH TENDER OFFER FOR UP TO $836.347 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS OUTSTANDING NOTES.  Full Article

Anthem Announces Results Of Its Tender Offer For Notes Due 2034, 2036, 2037, 2040 And 2044
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Anthem Inc ::ANTHEM ANNOUNCES RESULTS OF ITS TENDER OFFER FOR NOTES DUE 2034, 2036, 2037, 2040 AND 2044 AND UPSIZING OF THE MAXIMUM PURCHASE AMOUNT.ANTHEM - ANNOUNCED RESULTS OF PREVIOUSLY ANNOUNCED CASH TENDER OFFER FOR UP TO $600 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS MAXIMUM TENDER OFFER NOTES.ANTHEM INC- ‍RAISED MAXIMUM PURCHASE AMOUNT FROM $600 MILLION TO $836.347 MILLION​.  Full Article

Anthem announces pricing of its tender offer for any and all of its 7 pct notes due 2019
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Anthem Inc :Anthem announces pricing of its tender offer for any and all of its 7.000 pct notes due 2019.‍Pricing of its cash tender offer for any and all of its outstanding 7.000pct notes due 2019​.‍Any and all notes offer will expire at 5:00 p.m., New York City time, on November 20, 2017​.  Full Article

UPDATE 5-UnitedHealth 2nd-qtr medical costs miss estimates, shares slide

July 17 UnitedHealth Group Inc, the largest U.S. health insurer, on Tuesday reported second-quarter medical costs slightly higher than Wall Street expectations, sending its shares down 4 percent and weighing on the rest of the sector.